Is it a worry when the percentage gainers are all low-priced stocks? For some it may be, others will just say it is the normal process.
Cybex International, Inc. (NASDAQ: CYBI) is up 23% at $1.47 and only on 202,000 shares of volume. This is on the heels the company reaching a settlement in the Barnhard product liability suit.
The McClatchy Company (NYSE: MNI) is up 24% at $2.78 and not quite on 2 million shares as of yet. This surge is after the company beat its earnings predictions and after tuting its digital efforts in the world of old media meets new media.
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) is up 17% on 2.8 million shares at $2.40. Biomimetic’s news is that the company announced results of its 30 patient Canadian Augment Rotator Cuff Graft clinical trial and that the results achieved the primary safety endpoint.
Standard Pacific Corp. (NYSE: SPF) is up 18.5% to $4.80 on 6.7 million shares. The single-family homebuilder announced earnings ahead of estimates.